⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Hepatic cell carcinoma✘Cholangiocarcinoma
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 49%(0)87%(8)
General urine test —100%(4)
Histological studies 18%(0)38%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 100%—
Register, to see more distinctive signs of diseases and studies —21%
cancer 74% 13%
cholangiocarcinoma 4% 24%
oncology 46% 12%
gallbladder cancer — 19%
ascites 26% —
cholestasis — 17%
solid tumors 24% —
sclerosing cholangitis — 16%
effects of chemotherapy 24% —
gallbladder stones — 16%
breast cancer 23% —
hypertrophy biliary tract — 16%
benign neoplasms 35% 13%
chronic cholangitis — 16%
cell carcinoma colon cancer 19% —
cancer of the extrahepatic biliary tract — 16%
stomach cancer 19% —
opsouria — 14%
gastric adenocarcinoma 18% —
itchy skin — 14%
breast tumor 18% —
pancreatic sclerosis — 13%
stomach tumors 18% —
rapid weight loss — 13%
chronic viral hepatitis 14% —
pancreatic cancer — 13%
hepatitis chronic 13% —
loss body weight — 13%
increased ESR 13% —
dysfunction of the gallbladder 3% 15%
radiation therapy 23% 9%
anomalies of the gallbladder development — 12%
viral hepatitis b 12% —
opisthorchiasis — 12%
liver transplantation 11% —
impaired function of the bile ducts — 12%
radiation damage 22% 9%
urobilinogen lowered — 12%
enlarged liver 10% —
no appetite — 12%
a history of organ transplantation 9% —
primary sclerosing cholangitis — 12%
painful swelling 9% —
nausea during meals — 11%
erythropoietin reduced 9% —
colitis — 11%
lymphosarcoma 9% —
tumor collapse syndrome — 11%
expansion of the esophagus 9% —
purulent cholangitis — 11%
liver metastases 8% —
nausea — 11%
lowered 8% —
leptospirosis — 11%
consequences of infection 8% —
increased direct bilirubin — 11%
hemangioma 7% —
no feeling of hunger — 11%
paraneoplastic syndrome 7% —
bilirubinuria — 11%
venous bleeding 7% —
acholic feces — 10%
alcoholic liver disease 7% —
inflammatory bowel diseases — 10%
liver sarcoma 7% —
helminths — 10%
bone cancer 7% —
dark urine — 10%
hepatitis A 7% —
history of pancreatic surgery — 10%
bone metastases 7% —
rectal cancer — 10%
tumors of the large intestine 18% 9%
biliary cirrhosis of the liver — 10%
parathyroid hormone reduced 6% —
itching of the skin of the abdomen — 10%
erythrocytosis 6% —
primary-multiple tumors — 9%
porphyria 6% —
soreness of the skin — 9%
abdominal surgery 6% —
helps others — 9%
better in morning 6% —
itching of the body — 9%
thrombosis 6% —
acute colitis — 9%
increased endurance 6% —
vomiting — 9%
better in afternoon 6% —
tumors of the rectum — 9%
liver failure 6% —
squamous cell carcinoma — 9%
history of vein surgery 6% —
black feces — 9%
portal vein thrombosis 6% —
chronic cholecystitis — 9%
hypoglycemia 6% —
worse before eating — 9%
onset of illness 6% —
feeling of uselessness — 8%
increased calcium 6% —
infectious colitis — 8%
tyrosinemia 6% —
crohn — 8%
tumour in the abdomen 6% —
dense tumor — 8%
osteosarcoma 6% —
cholecystitis — 8%
adenocarcinoma of the colon 6% —
enlarged lymph nodes — 8%
acute venous thrombosis 6% —
chronic colitis — 8%
hepatoblastoma 5% —
k94 diagnosis of gastrointestinal diseases 3% 11%
swelling of the right leg 5% —
hyperbilirubinemia — 8%
is generally worse on the right 5% —
change in appetite — 8%
benign tumors of the stomach 5% —
nausea vomiting — 7%
hepatosis 5% —
feeling of heat 2% 9%
роды и вскармливание 5% —
weight change — 7%
studies a lot 5% —
nausea from pain — 7%
tumors of the diaphragm 5% —
vascular damage — 7%
hepatosis fatty 5% —
papules — 7%
control issues 5% —
oncology in the anamnesis 5% 12%
increased bleeding 5% —
impaired function of the large intestine — 7%
brain cancer 5% —
pain in the gallbladder 4% 10%
leg pain fever 5% —
cancer in the anamnesis 5% 11%
chronic liver failure 5% —
angioplasty 5% 11%
portal vein dilated 5% —
exhaustion — 6%
impaired arterial function 5% —
trauma — 6%
sarcopenia 5% —
inflammation 2% 8%
liver atrophy 5% —
high temperature 2% 8%
fat deposits 5% —
changes in the blood — 6%
periodic illness 5% —
clonorchiasis — 5%
pain in the right leg 5% —
migrating larva 3% 8%
bleeding 5% —
right-sided symptoms 3% 8%
discomfort in the right hypochondrium 5% —
pain in the right hypochondrium 7% 12%
recovery period 5% —
jaundice 6% 10%
liver resection 16% 9%
worse during meals 3% 7%
bleeding ulcer 5% —
necrosis 2% 6%
impaired venous function 5% —
predominant right 4% 8%
blood diseases 5% —
acute pain 2% 6%
gastric bleeding 5% —
increased 8% 12%
metastatic brain tumors 5% —
vascular tumor 9% 13%
stage of recovery 5% —
general weakness 3% 7%
intestinal tumor 14% 7%
pain throughout the body 3% 7%
hemochromatosis 5% —
worse food 3% 7%
germinogenic tumors 5% —
liver cancer 14% 17%
obesity on the stomach 5% —
alpha fetoprotein increased 9% 12%
с22 5% —
peptic ulcer 4% 7%
congenital liver fibrosis 5% —
history of surgery 9% 12%
impaired gastric function 5% —
increase of the alkaline phosphatase 5% 8%
benign epithelial tumors 5% —
gastrointestinal problems 10% 12%
intestinal bleeding 5% —
skin problems 4% 6%
hepatic encephalopathy 4% —
acute viral hepatitis 8% 9%
hemorrhagic diathesis 4% —
intoxication 5% 6%
kaposi 's sarcoma 4% —
consequences of surgery 5% 6%
consequences of physical exertion 4% —
there are no complaints 5% 6%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.